These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 29543914)

  • 1. Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
    Scheibenbogen C; Loebel M; Freitag H; Krueger A; Bauer S; Antelmann M; Doehner W; Scherbakov N; Heidecke H; Reinke P; Volk HD; Grabowski P
    PLoS One; 2018; 13(3):e0193672. PubMed ID: 29543914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ß2-adrenergic receptors.
    Wirth K; Scheibenbogen C
    Autoimmun Rev; 2020 Jun; 19(6):102527. PubMed ID: 32247028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome.
    Loebel M; Grabowski P; Heidecke H; Bauer S; Hanitsch LG; Wittke K; Meisel C; Reinke P; Volk HD; Fluge Ø; Mella O; Scheibenbogen C
    Brain Behav Immun; 2016 Feb; 52():32-39. PubMed ID: 26399744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating the Association Between Soluble CD26 and Autoantibodies Against G-Protein Coupled Receptors, Immunological and Cardiovascular Parameters Identifies Distinct Patterns in Post-Infectious vs. Non-Infection-Triggered Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Szklarski M; Freitag H; Lorenz S; Becker SC; Sotzny F; Bauer S; Hartwig J; Heidecke H; Wittke K; Kedor C; Hanitsch LG; Grabowski P; Sepúlveda N; Scheibenbogen C
    Front Immunol; 2021; 12():644548. PubMed ID: 33889154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IA-PACS-CFS: a double-blinded, randomized, sham-controlled, exploratory trial of immunoadsorption in patients with chronic fatigue syndrome (CFS) including patients with post-acute COVID-19 CFS (PACS-CFS).
    Preßler H; Machule ML; Ufer F; Bünger I; Li LY; Buchholz E; Werner C; Beraha E; Wagner F; Metz M; Burock S; Bruckert L; Franke C; Wilck N; Krüger A; Reshetnik A; Eckardt KU; Endres M; Prüss H
    Trials; 2024 Mar; 25(1):172. PubMed ID: 38454468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption.
    Tölle M; Freitag H; Antelmann M; Hartwig J; Schuchardt M; van der Giet M; Eckardt KU; Grabowski P; Scheibenbogen C
    J Clin Med; 2020 Jul; 9(8):. PubMed ID: 32751659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report.
    Stein E; Heindrich C; Wittke K; Kedor C; Kim L; Freitag H; Krüger A; Tölle M; Scheibenbogen C
    J Clin Med; 2023 Oct; 12(19):. PubMed ID: 37835071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers in the diagnostic algorithm of myalgic encephalomyelitis/chronic fatigue syndrome.
    Gravelsina S; Vilmane A; Svirskis S; Rasa-Dzelzkaleja S; Nora-Krukle Z; Vecvagare K; Krumina A; Leineman I; Shoenfeld Y; Murovska M
    Front Immunol; 2022; 13():928945. PubMed ID: 36300129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease.
    Sotzny F; Blanco J; Capelli E; Castro-Marrero J; Steiner S; Murovska M; Scheibenbogen C;
    Autoimmun Rev; 2018 Jun; 17(6):601-609. PubMed ID: 29635081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies to beta-adrenergic and muscarinic cholinergic receptors in Myalgic Encephalomyelitis (ME) patients - A validation study in plasma and cerebrospinal fluid from two Swedish cohorts.
    Bynke A; Julin P; Gottfries CG; Heidecke H; Scheibenbogen C; Bergquist J
    Brain Behav Immun Health; 2020 Aug; 7():100107. PubMed ID: 34589868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered Structural Brain Networks Related to Adrenergic/Muscarinic Receptor Autoantibodies in Chronic Fatigue Syndrome.
    Fujii H; Sato W; Kimura Y; Matsuda H; Ota M; Maikusa N; Suzuki F; Amano K; Shin I; Yamamura T; Mori H; Sato N
    J Neuroimaging; 2020 Nov; 30(6):822-827. PubMed ID: 32609410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression.
    Maes M; Mihaylova I; Kubera M; Leunis JC; Twisk FN; Geffard M
    Metab Brain Dis; 2012 Dec; 27(4):415-23. PubMed ID: 22614823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single nucleotide polymorphisms and genotypes of transient receptor potential ion channel and acetylcholine receptor genes from isolated B lymphocytes in myalgic encephalomyelitis/chronic fatigue syndrome patients.
    Marshall-Gradisnik S; Johnston S; Chacko A; Nguyen T; Smith P; Staines D
    J Int Med Res; 2016 Dec; 44(6):1381-1394. PubMed ID: 27834303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postural Orthostatic Tachycardia Syndrome Is Associated With Elevated G-Protein Coupled Receptor Autoantibodies.
    Gunning WT; Kvale H; Kramer PM; Karabin BL; Grubb BP
    J Am Heart Assoc; 2019 Sep; 8(18):e013602. PubMed ID: 31495251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of Beta-Adrenergic Autoantibodies Over Time in Post-Viral ME/CFS is Related to Fatigue and Pain Symptoms.
    Busch L; Schriek C; Paul M; Heidecke H
    Isr Med Assoc J; 2023 Apr; 25(4):259-264. PubMed ID: 37129123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extended B cell phenotype in patients with myalgic encephalomyelitis/chronic fatigue syndrome: a cross-sectional study.
    Mensah F; Bansal A; Berkovitz S; Sharma A; Reddy V; Leandro MJ; Cambridge G
    Clin Exp Immunol; 2016 May; 184(2):237-47. PubMed ID: 26646713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the existence of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) with and without abdominal discomfort (irritable bowel) syndrome.
    Maes M; Leunis JC; Geffard M; Berk M
    Neuro Endocrinol Lett; 2014; 35(6):445-53. PubMed ID: 25433843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to Vasoregulative G-Protein-Coupled Receptors Correlate with Symptom Severity, Autonomic Dysfunction and Disability in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.
    Freitag H; Szklarski M; Lorenz S; Sotzny F; Bauer S; Philippe A; Kedor C; Grabowski P; Lange T; Riemekasten G; Heidecke H; Scheibenbogen C
    J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.